131 related articles for article (PubMed ID: 4362228)
41. The synthesis and characterization of the amino-terminal octapeptide of mouse nerve growth factor.
Hogue-Angeletti R; Bradshaw RA; Marshall GR
Int J Pept Protein Res; 1974; 6(5):321-8. PubMed ID: 4430560
[No Abstract] [Full Text] [Related]
42. Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract.
Saiga A; Okumura T; Makihara T; Katsuta S; Shimizu T; Yamada R; Nishimura T
J Agric Food Chem; 2003 Mar; 51(6):1741-5. PubMed ID: 12617616
[TBL] [Abstract][Full Text] [Related]
43. [Studies on the structure of aminopeptidase from particles of pig kidneys].
Wachsmuth ED
Biochem Z; 1967 Jan; 346(5):467-73. PubMed ID: 4293652
[No Abstract] [Full Text] [Related]
44. Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme.
Dorer FE; Kahn JR; Lentz KE; Levine M; Skeggs LT
Biochem Pharmacol; 1975 May; 24(10):1137-9. PubMed ID: 168899
[No Abstract] [Full Text] [Related]
45. Structure and activity of insulin. XII. Further studies on biologically acitve synthetic fragments of the B-chain.
Weitzel G; Eisele K; Schulz V; Stock W
Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):321-30. PubMed ID: 4803476
[No Abstract] [Full Text] [Related]
46. Fluorescamine as a terminating agent in solid phase peptide synthesis.
Felix AM; Jimenez H; Vergona R; Cohen MR
Int J Pept Protein Res; 1975; 7(1):11-22. PubMed ID: 1120631
[TBL] [Abstract][Full Text] [Related]
47. [Peptide syntheses in the aqueous phase. Synthesis of some peptides and a mixture of erratic sequence peptide by the n-carboxyanhydride method (author's transl)].
Pfaender P; Kuhnle E; Krahl B; Backmansson A; Gnauck G; Blecher H
Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):267-85. PubMed ID: 4154269
[No Abstract] [Full Text] [Related]
48. The solid phase syntheses of 5-isoleucine-angiotensin I and 5-isoleucine (10-14C(U),-leucine)-angiotensin I.
Thampi NS; Schoellmann G; Hurst MW; Huggins CG
Life Sci; 1968 Jun; 7(12):641-5. PubMed ID: 4299705
[No Abstract] [Full Text] [Related]
49. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
Poe M; Wu JK; Lin TY; Hoogsteen K; Bull HG; Slater EE
Anal Biochem; 1984 Aug; 140(2):459-67. PubMed ID: 6385771
[TBL] [Abstract][Full Text] [Related]
50. Nature of the pressor substance in rabbit placenta.
Ziegler M; Riniker B; Gross F
Biochem J; 1967 Jan; 102(1):28-32. PubMed ID: 4292638
[TBL] [Abstract][Full Text] [Related]
51. The high-performance liquid chromatographic analysis of diastereomers and structural analogs of angiotensins I and II.
Margolis SA; Konash PL
Anal Biochem; 1983 Oct; 134(1):163-9. PubMed ID: 6660487
[TBL] [Abstract][Full Text] [Related]
52. Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment-1. [Tyr47, Nle53] preprorenin-(47-60) peptide methyl ester.
Fehrentz JA; Seyer R; Heitz A; Fulcrand P; Castro B; Corvol P
Int J Pept Protein Res; 1986 Dec; 28(6):620-7. PubMed ID: 3546171
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of [1-Isoleucine-, 3-proline-, and 5-alanine]-angiotensins. II.
Khosla MC; Chaturvedi NC; Smeby RR; Bumpus FM
Biochemistry; 1968 Oct; 7(10):3417-21. PubMed ID: 4386645
[No Abstract] [Full Text] [Related]
54. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
55. Substrate requirements for angiotensin I conversion in vivo and in vitro.
Oparil S; Koerner T; Tregear GW; Barnes BA; Haber E
Circ Res; 1973 Apr; 32(4):415-23. PubMed ID: 4349742
[No Abstract] [Full Text] [Related]
56. Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration.
Lazar J; Oster P; Gross F; Hackenthal E
Biochem Pharmacol; 1974 Oct; 23(19):2776-8. PubMed ID: 4371322
[No Abstract] [Full Text] [Related]
57. Pepstatin: lack of inhibition of the human renin-angiotensinogen reaction.
García RL; Croxatto HR; Roblero JS
Acta Physiol Lat Am; 1974; 24(1):92-3. PubMed ID: 4372859
[No Abstract] [Full Text] [Related]
58. Blood pressure and plasma angiotensin II concentration after renal artery constriction and angiotensin infusion in the dog. (5-Isoleucine)angiotensin II and its breakdown fragments in dog blood.
Caravaggi AM; Bianchi G; Brown JJ; Lever AF; Morton JJ; Powell-Jackson JD; Robertson JI; Semple PF
Circ Res; 1976 Apr; 38(4):315-21. PubMed ID: 1260974
[TBL] [Abstract][Full Text] [Related]
59. Fluorogenic peptides containing only alpha-amino acids.
Wang W; Liang TC
Biochem Biophys Res Commun; 1994 Jun; 201(2):835-40. PubMed ID: 8003020
[TBL] [Abstract][Full Text] [Related]
60. Renin: inhibition by proteins and peptides.
Workman RJ; McKown MM; Gregerman RI
Biochemistry; 1974 Jul; 13(15):3029-35. PubMed ID: 4601428
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
